(Q47596609)

4 February 2018

title

Modification of natural killer activity of lymphocytes infiltrating human lung cancers. (English)

1 reference

4 February 2018

author name string

T M Anderson

1

1 reference

4 February 2018

Y Ibayashi

2

1 reference

4 February 2018

E C Holmes

3

1 reference

4 February 2018

S H Golub

4

1 reference

4 February 2018

publication date

1 January 1987

1 reference

4 February 2018

Cancer Immunology, Immunotherapy

published in

1 reference

4 February 2018

volume

25

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

65-68

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00199303

exact match

0 references

cites work

Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity

1 reference

12 December 2020

Production of prostaglandin E2 by bladder tumor cells in tissue culture and a possible mechanism of lymphocyte inhibition

1 reference

12 December 2020

Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. II. Functional investigations of the infiltrating inflammatory cells.

1 reference

12 December 2020

Augmentation of natural killer activity of human peripheral blood lymphocytes by human leukocyte interferon: characterization of the augmented activity

1 reference

12 December 2020

Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins

1 reference

12 December 2020

Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

12 December 2020

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

12 December 2020

Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

1 reference

12 December 2020

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1 reference

12 December 2020

Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours

1 reference

12 December 2020

In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

1 reference

12 December 2020

Lymphoid cells infiltrating human pulmonary tumors: effect of intralesional BCG injection

1 reference

12 December 2020

Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes

1 reference

12 December 2020

Extravascular natural cytotoxicity in man: Anti-K562 activity of lymph-node and tumour-infiltrating lymphocytes

1 reference

12 December 2020

Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activities

1 reference

12 December 2020

Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity

1 reference

12 December 2020

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor

1 reference

12 December 2020

Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population

1 reference

12 December 2020

A method for improved yield and purity in extracting lymphocytes from lung tumors

1 reference

12 December 2020

Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2.

1 reference

12 December 2020

Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).

1 reference

12 December 2020

Interferon-induced NK augmentation in humans. An analysis of target recognition, effector cell recruitment and effector cell recycling

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199303

1 reference

4 February 2018

PubMed ID

3109739

1 reference

4 February 2018